The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Goa is a small state on the western coast of India, famous for its beaches,…
Every year, people around the world search for words that show what interests them the…
The Hurun Rich List 2025 has once again highlighted India’s dynamic startup and business ecosystem.…
India’s innovation ecosystem has received global recognition as an Indian satellite internet concept emerged as…
India’s fiscal position showed resilience in the current financial year as net direct tax collections…
Recently, the Union Minister informed the Rajya Sabha about the progress and impact of the…